Teva Pharmaceutical Industries Limited Sponsored ADR Stock

$18.08

1.90% day before yesterday

NYSE, Sep 06, 10:10 pm CET

ISIN

US8816242098

Symbol

TEVA

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Teva Pharmaceutical Industries Limited Sponsored ADR Stock price

$18.08

+11.07 157.92% 5Y

NYSE, Closing price Fri, Sep 06 2024

-0.35 1.90%

ISIN

US8816242098

Symbol

TEVA

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health

Industry

Pharmaceuticals

Key metrics

Market capitalization	$20.48b
Enterprise Value	$37.35b
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	18.01
EV/Sales (TTM) EV/Sales	2.29
P/S ratio (TTM) P/S ratio	1.26
P/B ratio (TTM) P/B ratio	3.22
Revenue growth (TTM) Revenue growth	8.38%
Revenue (TTM) Revenue	$16.30b
EBIT (operating result TTM) EBIT	$3.51b
Free Cash Flow (TTM) Free Cash Flow	$2.07b
Cash position	$2.26b
EPS (TTM) EPS	$-0.39
P/E forward	21.19
P/S forward	1.26
EV/Sales forward	2.30
Short interest	2.13%

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Get Started for Free Today

Teva Pharmaceutical Industries Limited Sponsored ADR Stock Analysis

Unlock Scores for Free

??

11 Analysts have issued a Teva Pharmaceutical Industries Limited Sponsored ADR forecast:

8x Buy

73%

3x Hold

27%

More details on Analyst Estimates Including Price Targets

11 Analysts have issued a Teva Pharmaceutical Industries Limited Sponsored ADR forecast:

Buy

73%

Hold

27%

Analyst Estimates with Stock Price Targets

Financial data from Teva Pharmaceutical Industries Limited Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '24		+/- %
Revenue	16,301 16,301	8% 8% 100%
- Direct Costs	8,228 8,228	0% 0% 50%
Gross Profit	8,073 8,073	18% 18% 50%
- Selling and Administrative Expenses	2,490 2,490	14% 14% 15%
- Research and Development Expense	991 991	15% 15% 6%
EBITDA	4,592 4,592	21% 21% 28%
- Depreciation and Amortization	1,080 1,080	12% 12% 7%
EBIT (Operating Income) EBIT	3,512 3,512	37% 37% 22%
Net Profit	-443 -443	80% 80% -3%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Teva Pharmaceutical Industries Limited Sponsored ADR Stock News

Neutral

Business Wire

●

3 days ago

Medincell's Partner Teva Provides New Update on Pivotal Clinical Phase 3 of Investigational Olanzapine Long-Acting Injectable (LAI)

MONTPELLIER, France--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced during the 22nd Annual Global Healthcare Conference held yesterday that c.99% of the targeted injections for submission have been performed as of today (replay available here). Teva also confirmed that the full submission safety results are expecte...

Neutral

Seeking Alpha

●

3 days ago

Teva Pharmaceutical Industries Limited (TEVA) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)

Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Morgan Stanley 22nd Annual Global Healthcare Conference Call September 4, 2024 11:30 AM ET Company Participants Richard Francis - Chief Executive Officer Conference Call Participants Thibault Boutherin - Morgan Stanley Thibault Boutherin So, good morning, everyone, and thank you for joining this session of the Morgan Stanley Global Healthcare ...

Positive

Schaeffers Research

●

9 days ago

2 Reasonably Priced Stocks to Keep an Eye On

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) and Hewlett Packard Enterprise Co (NYSE:HPE) are this week's picks for Schaeffer's Cheap Seats : Stocks Under $20 segment.

More Teva Pharmaceutical Industries Limited Sponsored ADR News

Company Profile

Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. Its products include medicines for cardiovascular diseases, pain relievers, obesity, cancer and supportive care, infectious diseases and human immunodeficiency viruses, and colds and coughs. The company was founded in 1901 and is headquartered in Petah Tikva, Israel.

Head office	Israel
CEO	Richard Francis
Employees	37,226
Founded	1901
Website	www.tevapharm.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now